Analyst Ratings for MAP Pharmaceuticals (MAPP)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 2.9 / 10
Percentile Rank: 24%
Rating Score: 2.9 / 10
Percentile Rank: 24%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/1/2013 | Wedbush | N/A | Downgrade | Neutral (Outperform) |
N/A (N/A) |
25.00 (27.25) |
9% | Details |
| 2/1/2013 | Ladenburg Thalmann | N/A | Downgrade | Neutral (Buy) |
N/A (N/A) |
24.77 (27.25) |
10.01% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
